Enjoyed speaking with Bruno @Larvol about advances in GI cancer including Claudin18.2, FGFR2, KRAS targeting, and bispecifics that have been discussed so far at #GI26
Uncategorized
1
Posts
1
Posters
0
Views
-
Enjoyed speaking with Bruno @Larvol about advances in GI cancer including Claudin18.2, FGFR2, KRAS targeting, and bispecifics that have been discussed so far at #GI26
We also had a nice discussion about precision oncology and @WIN_Consortium @Dr_R_Kurzrock
-
I med-mastodon.com shared this topic